This follow up study aims to refine the roles of previously suggested candidate genes (CC chemokine ligands or CCLs) in multiple sclerosis (MS), and to test these markers in another autoimmune disorder, systemic lupus erythematosus (SLE). After stringent correction for multiple testing, we reject the importance of previously suggested borderline associations with CCLs in MS. A new finding is the differential distribution of CCL8 marker alleles and a haplotype in extreme severity subgroups of MS. In SLE, this study reveals strong associations with a marker and a haplotype encompassing the CCL14 gene, which suggests that a lupus relevant variant may lie within or in the proximity of this haplotype. Published by Elsevier B.V.
Introduction
The development of autoimmunity is defined by complex interactions among genetic and environmental factors (Perl, 2004) . A genetic predisposition is suggested by disease concordance rates of 25% or higher in monozygotic twins in both organ-specific and systemic autoimmmunity such as multiple sclerosis (MS) and systemic lupus erythematosus (SLE) (Perl, 2004) . The Human Leukocyte Antigen (HLA) (6p21) locus has the largest impact on susceptibility for MS (IMSGC, 2007) and SLE (Nath et al., 2004) . In MS, the HLA DRB1 ⁎ 1501 allele appears to have the main role in Caucasians (Oksenberg et al., 2004) , but epistatic interactions among alleles aligning in the DR2 (DRB1-DRB5) haplotype have functional significance (Gregersen et al., 2006) and trans interactions among DRB1 susceptibility (e.g. DRB1 ⁎ 15, DRB1 ⁎ 17, DRB1 ⁎ 0301) and protective (e.g. DRB1 ⁎ 14, DRB1 ⁎ 11, DRB1 ⁎ 01, DRB1 ⁎ 10) allele combinations also play a role (Ramagopalan et al., 2007) . In addition, HLA locus heterogeneity also exists in MS (de Jong et al., 2002; IMSGC, 2005; Brynedal et al., 2007) . A recent whole genome association (WGA) in over 12,000 subjects shows very strong associations (p =8.94×10
− 81 ) for SNPs in the DRA locus, further confirming the importance of HLA in MS (IMSGC, 2007) . In SLE, the HLA-DR2 and DR3 alleles as well as Class III mutations leading to deficiency in complements 2 and 4 are important determinants of disease susceptibility (Arnett and Reveille, 1992) .
In contrast, non-HLA loci confer small risk to these disorders. Only studies in very large cohorts could conclusively identify disease variants in genes of IL2Rα (10p15) and IL7Rα (5p13) relevant for MS (Gregory et al., 2007; IMSGC, 2007; Lundmark et al., 2007) . Likewise, SNPs in ITGAM (Harley et al., 2008) and STAT4 genes were recently associated with SLE (Remmers et al., 2007) . CC chemokine ligand (CCL) genes control the differentiation, activation, and migration of immune cells, and their functional importance was repeatedly demonstrated in experimental autoimmune encephalomyelitis (EAE), MS (Mahad et al., 2004; Banisor et al., 2005; SavarinVuaillat and Ransohoff, 2007) and SLE (Wu et al., 2007; Rovin, 2008 
